StockNews.com Upgrades Oramed Pharmaceuticals (NASDAQ:ORMP) to “Buy”
StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Free Report) from a hold rating to a buy rating in a research note published on Wednesday morning. Separately, HC Wainwright reissued a neutral rating on shares of Oramed Pharmaceuticals in a report on Monday, September 9th. Check Out Our Latest Stock Report on Oramed Pharmaceuticals Oramed […]
21 Sep 07:55 · The Markets Daily